Tadataka Yamada

Co-Founder at Outpost Medicine LLC

Tadataka Yamada

Tadataka Yamada

Co-Founder at Outpost Medicine LLC

Overview
Career Highlights

Bill & Melinda Gates Foundation
American Gastroenterological Association
Association of American Physicians

RelSci Relationships

4886

Number of Boards

27

Birthday

06/1946

Age

74

Number of Awards

3

Relationships
RelSci Relationships are individuals Tadataka Yamada likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

General Partner, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Managing Partner, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Co-Founder at Scout Bio, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Accelerator Services Corp.

Relationship likelihood: Strong

Chief Executive Officer, President & Director at Passage Bio, Inc.

Relationship likelihood: Strong

Entrepreneur-in-Residence, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

Partner & Head of Growth Equity Investments at Adams Street Partners Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Agilent Technologies, Inc.

Relationship likelihood: Strong

Managing Director at ARCH Venture Partners

Relationship likelihood: Strong

Paths to Tadataka Yamada
Potential Connections via
Relationship Science
You
Tadataka Yamada
Co-Founder at Outpost Medicine LLC
Education
MD
Class of 1971

NYU School of Medicine has a proud history that goes back to 1837 and includes initiation of and participation in many of the major events in American medicine through two centuries. In 1837, six years after the granting of the first University charter, the minutes of the meetings of the University Council contained the names of men suggested as professors for the chief branches of medical instruction. In 1841, the University Medical College was organized, and instruction was begun under the following: Surgery, Anatomy; Chemistry; Theory and Practice of Medicine; Institutes of Medicine and Materia Medical; Obstetrics and Diseases of Women and Children. Clinical instruction was started in Bellevue Hospital in 1847, and in 1861 Bellevue Hospital Medical College was founded when a college building was erected on the hospital grounds. With the passing of the years and a deepening conviction that the total medical enterprise should be placed in the scholarly setting of the University, it became clear that University Medical College and Bellevue Hospital Medical College would benefit by consolidating. Thus, the medical school became an integral part of New York University in 1898 under the name of University and Bellevue Hospital Medical College. In 1935 the name was changed to New York University College of Medicine and in 1960 to NYU School of Medicine. The School of Medicine celebrated its sesquicentennial year in 1991.

B.A. in History
Class of 1967

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Attendee

The University of California, Los Angeles School of Medicine known as the David Geffen School of Medicine at UCLA, is an accredited medical school located in Los Angeles, California, USA.

Memberships
Member
Current

Founded in 1780, the American Academy of Arts and Sciences is an independent policy research center that conducts multidisciplinary studies of complex and emerging problems. The Academy’s elected members are leaders in the academic disciplines, the arts, business, and public affairs. With a current membership of 4,000 American Fellows and 600 Foreign Honorary Members, the Academy has four major goals: Promoting service and study through analysis of critical social and intellectual issues and the development of practical policy alternatives; Fostering public engagement and the exchange of ideas with meetings, conferences, and symposia bringing diverse perspectives to the examination of issues of common concern; Mentoring a new generation of scholars and thinkers through the Visiting Scholars Program and Hellman Fellowship Program; Honoring excellence by electing to membership men and women in a broad range of disciplines and professions. Click here to learn about our new members. The Academy's headquarters are in Cambridge, Massachusetts. With its geographically diverse membership, it conducts activities in this country and abroad

Member
Current

The National Academy of Medicine (NAM), formerly called the Institute of Medicine (IoM), is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC). The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health. It aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large. Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.

Career History
Co-Founder
2016 - Current

Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA.

Venture Partner, Life Sciences Team
2006 - Current

Frazier Management invests in lower middle-market healthcare companies with $5-50 million in EBITDA and makes equity commitments ranging from $30-350 million. Investments take the form of buyouts, recapitalizations and corporate carveouts.

Co-Founder
Current

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Boards & Committees
Member, Board of Directors
2015 - Current

Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA.

Chairman
1994 - Prior

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.

Director
Prior

Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $10K
2019

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

$1 - $10K
2018

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

$625
2018

THE VERO BEACH MUSEUM OF ART PROVIDES CULTURAL LEADERSHIP AND ENRICHMENT FOR THE PUBLIC THROUGH A WIDE VARIETY OF EDUCATIONAL, STUDIO ART AND HUMANITIES PROGRAMS; A DIVERSITY OF QUALITY EXHIBITIONS; AND THE COLLECTION, PRESERVATION AND PRESENTATION OF IMPORTANT AMERICAN AND INTERNATIONAL WORKS OF ART.

Political Donations
$2,000
2005
$1,000
2004

Representative from New Jersey's 7th Congressional District

$1,000
2004

Senator at Office of the Senator from Alaska, Daniel S. Sullivan

Transactions
Details Hidden

Passage Bio, Inc. raised money in a private placement transaction

Details Hidden

Takeda Pharmaceutical Co., Ltd., Takeda America Holdings, Inc. purchase LigoCyte Pharmaceuticals, Inc. from MedImmune Ventures, Forward Ventures Services LLC, Icon Ventures LLC, Novartis Venture Fund, Athenian Venture Partners, F-Prime Capital Partners, RAIN Source Capital, Inc., Glacier Venture Fund, MIC Capital LLC

Investments
Details Hidden

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Details Hidden

Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA.

Details Hidden

Ingenuity Systems, Inc. provides intuitive web-based applications for quickly analyzing and accurately interpreting the biological meaning of genomics data. The company was founded in 1998 and is headquartered in Redwood City, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Washington College
University of East Anglia
University of Warwick
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tadataka Yamada. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tadataka Yamada's profile does not indicate a business or promotional relationship of any kind between RelSci and Tadataka Yamada.